Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• ADO09 formulation (drug)
• NovoRapid® (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Profil Institut für Stoffwechselforschung GmbH
  Neuss, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• I-PORT (device)
• standard injections (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Texas Diabetes & Endocrinology, PA
  Austin, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Amylin (Pramlintide) (other)
• CGRP (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Danish Headache Center
  Glostrup Municipality, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 24-hour inpatient intervention (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• McGill University Health Centre
  Montreal, Quebec, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• ADO09 formulation (drug)
• Placebo (drug)
• Symlin® (drug)
• Humulin® (drug)
• Humalog® (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Profil Institut für Stoffwechselforschung GmbH
  Neuss, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• BC Pram Ins (drug)
• Symlin® and Humulin® (drug)
• Humalog® (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Profil Institut für Stoffwechselforschung GmbH
  Neuss, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug) — also listed as: Symlin
• Glargine (drug)
• Lispro (drug)
• Aspart (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UT Southwestern at Dallas
  Dallas, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug) — also listed as: Amylin
• Placebo (drug) — also listed as: sterile saline

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The University of Texas Southwestern Medical Center
  Dallas, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide acetate (drug) — also listed as: Pramlintide: SYMLIN
• Placebo (drug)
• Lispro insulin U-100 (drug) — also listed as: Humalog insulin lispro U-100
• Regular insulin U-100 (drug) — also listed as: Humulin R; U-100

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Research Site
  Chula Vista, California, United States
  Site recruitment: Not reported
• Research Site
  Portland, Oregon, United States
  Site recruitment: Not reported
• Research Site
  Chattanooga, Tennessee, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Colorado Denver
  Aurora, Colorado, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Insulin (drug) — also listed as: aspart or lispro
• Pramlintide + Insulin (drug) — also listed as: Pramlintide Acetate

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Montefiore Medical Center
  The Bronx, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug) — also listed as: Symlin
• Exenatide (drug) — also listed as: Byetta, Type 1 diabetes
• Insulin (drug) — also listed as: Novolog, Humalog, Levemir, Lantus

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Albert Einstein College of Medicine West Campus Clinical Research Center
  The Bronx, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Medtronic ePID 2.0 (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Albert Einstein College of Medicine CRC
  The Bronx, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Byetta (exenatide) (drug)
• Symlin (pramlintide) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Baylor College of Medicine
  Houston, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug) — also listed as: Symlin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Texas Children's Hospital
  Houston, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Baylor College of Medicine
  Houston, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide and glucagon (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Baylor College of Medicine
  Houston, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide acetate (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Royal Adelaide Hospital
  Adelaide, South Australia, Australia
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Pramlintide acetate (drug) — also listed as: Symlin (pramlintide acetate)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Orlando Clinical Research Center
  Orlando, Florida, United States
  Site recruitment: Not reported
• New Orleans Center for Clinical Research
  New Orleans, Louisiana, United States
  Site recruitment: Not reported
• DaVita Clinical Research
  Minneapolis, Minnesota, United States
  Site recruitment: Not reported
• CEDRA Clinical Research, LLC
  Austin, Texas, United States
  Site recruitment: Not reported